Binimetinib | Interleukin Related interleukin-related.com

Product Name :
Binimetinib

Search keywords :
MEK2

drugId :
null

Target Vo:
Dual specificity mitogen-activated protein kinase kinase 2

Target Vo Short Name :
MEK2

Moa_Name:
Dual specificity mitogen-activated protein kinase kinase 1 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2018

Origin Company_Name :
Array Biopharma

Active Company_Name :
Almac Pharma Services Ltd

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Leukemia

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Collagen I alpha 2 Antibody
CD68 Antibody (YA798)
p38 Antibody: p38 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to p38. It can be used for WB,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts